Javascript must be enabled to continue!
A COMPARISON OF CEFTRIAXONE AND CIPROFLOXACIN’S EFFICACY IN THE TREATMENT OF GONORRHOEA
View through CrossRef
Introduction: A bacterial illness that is extremely infectious and spreads via sexual contact between men and women,gonorrhea is a serious public health problem. It is among the most ancient sexually transmitted infections (STDs), andNeisseria is the cause. Rarely, gonorrhea may also result in pharyngeal, ocular, articular, and dermatological diseasesin addition to its predominant urogenital signs and symptoms. Various antibiotics, including spectinomycin, penicillins,tetracyclines, macrolides, fluoroquinolones, and sulpha medicines, have been used to treat gonorrhea. Some of thesemedicines have become less effective in treating gonorrhea due to an increase in resistant infections.Objective: This research compared the efficaciousness of Ceftriaxone and Ciprofloxacin in managing gonococcalinfections.Study Design: Observational Study.Place of Duration of Study: The research was carried out from January 2003 to March 2004 at the NewGulail Polyclinic in Saudi Arabia.Material and Methods: With the Institutional Ethical Committee’s consent, 200 patients received Ceftriaxoneand Ciprofloxacin to treat gonorrhea. Enrolling the patients included the use of a purposeful sampling approach. Everypatient was split into two groups of 100 individuals, each at random. Group B received a single intravenous dose of500 mg of Ceftriaxone injection, whereas Group A received a 500 mg tablet of Ciprofloxacin. After five days, allof the patients had follow-up exams, and the results of their lab and clinical examinations were noted and evaluated.Results: Patients in Group A (n=100) receiving Ciprofloxacin demonstrated 80% full response, 9% partial response,and 11% no response on the fifth day after treatment. In contrast, patients in Group B (n=100) receiving Ceftriaxonedemonstrated 90% full response, 4% partial response, and 6% no response.Conclusion: Ceftriaxone has shown superior efficacy in treating gonorrhea when compared to Ciprofloxacin. Aftertaking an antibiotic for the first time, it is advised that all patients have another examination to check that the gonorrhea has completely healed.Key Words: Neisseria gonorrhea, sexually transmitted infection (STI), Sexually Transmitted Disease
Bacha Khan Medical College
Title: A COMPARISON OF CEFTRIAXONE AND CIPROFLOXACIN’S EFFICACY IN THE TREATMENT OF GONORRHOEA
Description:
Introduction: A bacterial illness that is extremely infectious and spreads via sexual contact between men and women,gonorrhea is a serious public health problem.
It is among the most ancient sexually transmitted infections (STDs), andNeisseria is the cause.
Rarely, gonorrhea may also result in pharyngeal, ocular, articular, and dermatological diseasesin addition to its predominant urogenital signs and symptoms.
Various antibiotics, including spectinomycin, penicillins,tetracyclines, macrolides, fluoroquinolones, and sulpha medicines, have been used to treat gonorrhea.
Some of thesemedicines have become less effective in treating gonorrhea due to an increase in resistant infections.
Objective: This research compared the efficaciousness of Ceftriaxone and Ciprofloxacin in managing gonococcalinfections.
Study Design: Observational Study.
Place of Duration of Study: The research was carried out from January 2003 to March 2004 at the NewGulail Polyclinic in Saudi Arabia.
Material and Methods: With the Institutional Ethical Committee’s consent, 200 patients received Ceftriaxoneand Ciprofloxacin to treat gonorrhea.
Enrolling the patients included the use of a purposeful sampling approach.
Everypatient was split into two groups of 100 individuals, each at random.
Group B received a single intravenous dose of500 mg of Ceftriaxone injection, whereas Group A received a 500 mg tablet of Ciprofloxacin.
After five days, allof the patients had follow-up exams, and the results of their lab and clinical examinations were noted and evaluated.
Results: Patients in Group A (n=100) receiving Ciprofloxacin demonstrated 80% full response, 9% partial response,and 11% no response on the fifth day after treatment.
In contrast, patients in Group B (n=100) receiving Ceftriaxonedemonstrated 90% full response, 4% partial response, and 6% no response.
Conclusion: Ceftriaxone has shown superior efficacy in treating gonorrhea when compared to Ciprofloxacin.
Aftertaking an antibiotic for the first time, it is advised that all patients have another examination to check that the gonorrhea has completely healed.
Key Words: Neisseria gonorrhea, sexually transmitted infection (STI), Sexually Transmitted Disease.
Related Results
Antimicrobial resistance and molecular characteristics of N. gonorrhoea isolates in Ghana
Antimicrobial resistance and molecular characteristics of N. gonorrhoea isolates in Ghana
Introduction: Gonorrhoea is a disease associated with humans and caused by N. gonorrhoea. N. gonorrhoea’s ability to evolve and evade various treatment regimens can lead to untreat...
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults
Gonorrhoea is a major public health concern globally. Of particularly grave concern is that resistance to the extended-spectrum cephalosporins has emerged during the most recent ye...
Clinical Pharmacology of Ceftriaxone
Clinical Pharmacology of Ceftriaxone
Ceftriaxone is a third-generation cephalosporin and is resistant to many narrow-spectrum β-lactamases and has good activity against most gram-positive and gram-negative aerobic bac...
Barriers to accessibility of ceftriaxone among adult postoperative patients at Mulago National Referral Hospital, Uganda
Barriers to accessibility of ceftriaxone among adult postoperative patients at Mulago National Referral Hospital, Uganda
Abstract
Background: Access to ceftriaxone is still low, causing 11% of patients not to complete their treatment at health facilities in Uganda; which could increase antimi...
Antimicrobial resistance and molecular characteristics of N. gonorrhoea isolates in Ghana
Antimicrobial resistance and molecular characteristics of N. gonorrhoea isolates in Ghana
Gonorrhoea is a disease associated with humans and it is caused by N. gonorrhoea. N. gonorrhoea’s ability to evolve and evade various treatment regimens can lead to untreatable Gon...
Antimicrobial activity of ciprofloxacin-coated gold nanoparticles on selected pathogens
Antimicrobial activity of ciprofloxacin-coated gold nanoparticles on selected pathogens
Antibiotic resistance amongst bacterial pathogens is a crisis that has been worsening over recent decades, resulting in serious and often fatal infections that cannot be treated by...
Point-of-care testing improves accuracy of STI care in an emergency department
Point-of-care testing improves accuracy of STI care in an emergency department
ObjectivesWe aimed to examine the impact of a point-of-care (POC) test on overtreatment and undertreatment of sexually transmitted infections (STIs) by comparing treatment patterns...
EVALUATION OF CIPROFLOXACIN AND CEFTRIAXONE’S EFFICACY IN THE TREATMENT OF GONORRHOEA
EVALUATION OF CIPROFLOXACIN AND CEFTRIAXONE’S EFFICACY IN THE TREATMENT OF GONORRHOEA
INTRODUCTION: A very infectious bacterial illness that may infect both men and women via sexual contact isgonorrhea, a serious public health hazard. It is among the most ancient se...

